Samsung is developing a new technique that could revolutionise the early detection of Alzheimer’s signs using standard Galaxy watches and phones.
The tech giant’s experts created digital biomarkers that examine data passively gathered by wearables and smartphones.
This includes data like voice characteristics, sleep habits, call frequency, typing speed, and app usage to measure changes in cognitive function with great sensitivity. Because smartphones and wearables record a lot of user data, they may be able to identify tiny changes that point to early cognitive deterioration months before more conventional medical detection techniques.
Digital biomarkers track cognitive Health
Samsung’s digital biomarker technology uses AI to monitor behavioural and physiological signals continuously. For example, the system analyses keyboard typing patterns, walking gait, messaging habits, and speech fluency to create individual cognitive profiles.
Researchers explain that these indicators correlate with the brain areas affected by Alzheimer’s, including memory, language, and motor control.
Users don’t need to install additional apps or run specific tests because combining numerous data streams allows for very accurate danger detection without interfering with daily routines.
The AI provides real-time health insights while processing data directly on devices to protect privacy.
Samsung leads health Innovation With Galaxy devices
Samsung aims to advance preventive healthcare through its Galaxy devices by providing continuous, non-invasive monitoring of cognitive health.
This innovation builds on Galaxy watches’ established health features, such as fall detection and fitness tracking, by adding personalised assessments related to neurological wellness.
Dr Hon Pak, Samsung’s senior vice president of digital health, emphasises that supporting healthy behaviours and early detection can significantly impact disease management. With worldwide collaboration among scientists and clinical experts, Samsung’s technology promises to improve the quality of life by enabling intervention at the earliest signs of Alzheimer’s.